实用医学杂志 ›› 2021, Vol. 37 ›› Issue (21): 2817-2821.doi: 10.3969/j.issn.1006⁃5725.2021.21.023

• 综述 • 上一篇    下一篇

干细胞移植治疗缺血性脑卒中的研究与进展 

廖益东1 王梓力1 陈光唐1 王旭东1 徐卡娅2   

  1. 1 贵州医科大学(贵阳 550004);2 贵州医科大学附属医院(贵阳 550004)

  • 出版日期:2021-11-10 发布日期:2021-11-10
  • 通讯作者: 徐卡娅 E⁃mail:xkaya@sina.com
  • 基金资助:
    国家自然科学基金项目(编号:81901173,82060231);贵州省普通高等学校青年科技人才成长项目(编号:黔教合 KY字[2021]190);贵州医科大学 2018 年度学术新苗培养及创新探索专项项目(编号:黔科合平台人才[2018]5779⁃44)

Research progress on stem cell transplantation for ischemic stroke

LIAO Yidong*,WANG Zili,CHEN Guangtang,WANG Xudong,XU Kaya.   

  1. The First Clinical Medical School,Guizhou Medical University,Guiyang 550004,China 

  • Online:2021-11-10 Published:2021-11-10
  • Contact: XU Kaya E⁃mail:xkaya@sina.com

摘要:

缺血性脑卒中是一种全球病死率和致残率极高的疾病,临床上国内外的大多数报道都与脑 血管病变闭塞有关,急需新的治疗手段进行干预。干细胞可以分泌神经营养因子,替换受损的神经元、通 过抑制颅内外炎症反应和抗细胞凋亡发挥神经保护作用,还可释放营养和生长因子等增强内源性修复机 制的物质而起到神经保护及修复的作用,所以移植干细胞治疗缺血性脑卒中有望为这类疾病的治疗提供 新选择。本文现从移植干细胞治疗缺血性脑卒中的作用机制及临床治疗运用、纳米材料在干细胞治疗中 的作用、移植后追踪监测干细胞影像学方法等对干细胞治疗缺血性脑卒中的研究进展做一综述,以供广 大医师在临床中治疗缺血性脑卒患者提供新的治疗选择与方案。

关键词:

干细胞, 移植, 缺血性脑卒中, 纳米颗粒, 基因工程联合细胞

Abstract:

Ischemic stroke is a disease with a high mortality and disability rate. According to most reports at home and abroad,its cause is related to cerebrovascular occlusion,and new treatment is urgently needed for clinical intervention. Stem cells can secrete neurotrophic factors to replace damaged neurons;they can play a neuro⁃ protective effect by inhibiting intracranial and extracranial inflammation and anti ⁃apoptosis. They can also release nutrients and growth factors that enhance endogenous repair mechanisms to protect and repair nerves. Therefore the use of stem cell transplantation to treat ischemic stroke is expected to become a new option. This article summa⁃ rizes the mechanism of stem cells transplantation in the treatment of ischemic stroke and its clinical application the role of nanomaterials in stem cell therapy,and post⁃transplantation tracking and monitoring of stem cell imag⁃ ing methods for stem cell treatment of ischemic stroke. 

Key words:

stem cell, transplant, ischemic stroke, nanoparticles, genetic engineering united cell